Article
Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC.
Molecular oncology - 1 May 2023
Wu Jun, Liu Zhiqiang, Huang Tianxiang, Wang Ying, Song Meng Meng, Song Tao, Long Gretchen, Zhang Xiaobing, Li Xi, Zhang Longbo
Abstract excerpt
Brain metastasis (BM) genetically diverges from the primary tumor in non-small-cell lung cancer (NSCLC). Hence, accurately capturing clinically relevant alterations is pivotal for the delivery of targeted therapies. Circulating tumor DNA (ctDNA) sequencing has emerged as a promising liquid biopsy in the biomarker-based clinical management of recurrent and extracranial metastatic NSCLC. However, the absence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
